Verified Insights
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
+91 9425150513 (Asia) support@24lifesciences.com
+91 9425150513 (Asia) support@24lifesciences.com
Download Sample Pdf
MARKET INSIGHTS
Global Disposable Endoscopic Injection Needle market was valued at USD 1,649 million in 2024 and is projected to reach USD 2,870 million by 2032, exhibiting a CAGR of 8.4% during the forecast period.
Disposable endoscopic injection needles are specialized medical devices used to deliver precise injections within internal cavities or organs during minimally invasive endoscopic procedures. These needles, available in various gauges such as 21G, 23G, 24G, 25G, and others, enable targeted administration of substances like sclerosants or medications in fields including gastroenterology and oncology.
The market is experiencing robust growth driven by the surge in minimally invasive procedures across specialties like pain management, gastroenterology, and oncology, which heightens demand for reliable injection tools. Technological advancements, including finer gauges and flexible designs, improve precision in delicate areas, while the emphasis on patient safety through disposables reduces infection risks compared to reusables. Furthermore, expanding applications in tumor ablation and drug delivery open new avenues. However, stringent regulatory hurdles and competition from catheter-based alternatives pose challenges. Leading players like Olympus, Boston Scientific, Cook Medical, and Micro-tech are innovating with diverse portfolios to capture market share and address evolving clinical needs.
Rising Demand for Minimally Invasive Procedures
The global shift toward minimally invasive surgeries is significantly driving the disposable endoscopic injection needle market. Hospitals and ambulatory surgery centers are increasingly adopting these devices due to their precision and reduced patient recovery times.
Growing Prevalence of Gastrointestinal Diseases
With the increasing incidence of gastrointestinal disorders globally, the demand for endoscopic procedures using disposable injection needles has surged. The WHO reports over 1.5 million new gastrointestinal cancer cases annually, necessitating advanced endoscopic interventions.
Market growth is projected at 12.3% CAGR through 2028, driven by technological advancements in needle design and manufacturing.
Healthcare infrastructure development in emerging markets is creating new opportunities for disposable medical device manufacturers, with countries like India and Brazil showing particularly strong growth potential.
MARKET CHALLENGES
High Cost of Advanced Endoscopic Systems
The initial investment required for state-of-the-art endoscopic systems with disposable component capabilities remains substantial, limiting adoption in budget-constrained healthcare facilities. A complete system can cost between $150,000 to $300,000, creating barriers for smaller hospitals.
Other Challenges
Regulatory Compliance and Certification
Navigating different regulatory requirements across global markets adds complexity and cost to product development. The FDA and EU MDR have stringent requirements for medical devices, requiring extensive clinical data and quality assurance protocols.
Technical Complexity of Miniaturization
As endoscopic procedures become more precise, the demand for smaller and more precise injection needles increases. Achieving sub-millimeter precision while maintaining structural integrity presents significant engineering challenges.
Limited Reimbursement Policies in Developing Regions
In many developing countries, healthcare reimbursement systems do not fully cover the cost of advanced endoscopic procedures using disposable components, limiting market penetration. This is particularly evident in regions where public healthcare systems dominate.
Emerging Markets with Growing Healthcare Infrastructure
Rapidly developing economies in Asia and Latin America are investing heavily in healthcare infrastructure, creating new opportunities for disposable medical device manufacturers. The medical device market in these regions is growing at 15-20% annually.
Technological Innovations in Biocompatible Materials
Advancements in material science are enabling the development of more efficient and safer endoscopic injection needles. New polymer blends and nano-coatings are improving performance while reducing costs, opening new market segments.
Integration with Robotic Surgery Systems
The rapid growth of robotic-assisted surgery presents significant opportunities for specialized endoscopic devices. With robotic systems achieving 25-30% annual growth, compatible disposable components are in high demand.
Segment Analysis:| Segment Category | Sub-Segments | Key Insights |
| By Type |
|
Medium-gauge needles (23G, 24G) are the leading segment, offering an optimal balance between injection flow rate and procedural precision. These gauges are favored in common therapeutic endoscopic procedures for their ability to deliver injectates effectively while minimizing trauma to delicate tissues. The ongoing trend towards minimally invasive techniques is driving innovation in needle tip design and flexibility within this category. Market dynamics show a clear preference for specific gauges tailored to clinical requirements, with finer gauges gaining traction for highly sensitive applications. |
| By Application |
|
Hospitals represent the dominant segment due to their high volume of complex endoscopic procedures, extensive surgical departments, and advanced infrastructure. The comprehensive nature of hospital care, including emergency interventions and specialized treatments in gastroenterology and oncology, creates sustained demand. Additionally, stringent hospital procurement protocols emphasizing patient safety and single-use devices solidify this segment's leadership. While clinics are growing for routine procedures, hospitals remain the primary center for innovation adoption and high-volume consumption of these specialized needles. |
| By End User |
|
Gastroenterology is the unequivocal leading segment, driven by the high frequency of endoscopic procedures like endoscopic mucosal resection and hemostasis. The critical need for precise injection in the gastrointestinal tract for diagnosis and treatment underpins this dominance. This specialty's well-established procedural protocols and the continuous expansion of therapeutic applications create a robust and predictable demand. While pulmonology and urology present significant growth avenues, gastroenterology's procedural volume and technological adoption rate maintain its primary position in the market. |
| By Distribution Channel |
|
Direct Sales is the leading distribution model, particularly for high-volume hospital accounts. Manufacturers favor this channel to maintain strong relationships with key healthcare providers, ensure proper product training, and provide dedicated technical support. This direct engagement is crucial for introducing complex new products and navigating the regulatory landscape. While distributors offer broader geographic reach for smaller clinics, the direct channel's ability to offer customized solutions and manage complex supply chains solidifies its importance in the market dynamics. |
| By Technology |
|
Standard Needles currently lead the market, valued for their reliability, established clinical protocols, and cost-effectiveness for a wide range of procedures. However, innovation is rapidly advancing, with significant growth potential for specialized technologies. Retractable safety needles are gaining prominence due to heightened focus on healthcare worker safety and needlestick injury prevention. Similarly, hydrodissection needles are emerging for advanced applications requiring precise tissue separation. The market demonstrates a clear trajectory from standard designs towards more sophisticated, application-specific technologies that enhance procedural outcomes and safety. |
A Market Characterized by Strategic Innovation and Established Leadership
The global disposable endoscopic injection needle market is moderately concentrated, with a few major multinational medical device corporations holding significant market share. Olympus Corporation stands as the dominant leader, leveraging its historical strength and extensive portfolio in the broader endoscopy market. Its brand recognition, global distribution network, and continuous investment in R&D for advanced needle designs, such as those with finer gauges for precise drug delivery, solidify its top position. Boston Scientific and Cook Medical are other key global players, competing through product innovation, strategic acquisitions, and strong relationships with healthcare providers. These leaders primarily compete on technological sophistication, product reliability, and comprehensive service support, catering to the high-volume hospital segment.
Beyond the top tier, the market features a diverse array of specialized and regional manufacturers that compete effectively by targeting niche applications or offering cost-competitive solutions. Companies like Micro-tech (Nanjing) Co., Ltd. and CONMED Corporation have established strong presences with their dedicated focus on minimally invasive surgical devices. A significant portion of the competitive landscape consists of rapidly growing manufacturers from the Asia-Pacific region, particularly China. Players such as Changzhou Jiuhong Medical, Jiangsu Grit Medical, and ZKSK Medical are increasing their market penetration by offering reliable products at competitive prices, addressing the cost-sensitivity of clinics and emerging markets. These companies are increasingly focusing on meeting international quality standards to expand their global footprint.
List of Key Disposable Endoscopic Injection Needle Companies ProfiledOlympus Corporation
STERIS plc
Micro-tech (Nanjing) Co., Ltd.
CONMED Corporation
Endo-Therapeutics
Upex-med
Changzhou Jiuhong Medical Instrument Co., Ltd.
Jiangsu Grit Medical Co., Ltd.
ZKSK Medical Instruments Co., Ltd.
AGS Medical
Shaili Endoscopy
Mermaid Medical
The global Disposable Endoscopic Injection Needle market is projected to grow significantly, with its value expected to increase from 1649 million in 2024 to US$ 2870 million by 2032, at a compound annual growth rate (CAGR) of 8.4%. This expansion is firmly rooted in the rising global adoption of minimally invasive procedures. Endoscopic techniques are increasingly preferred across specialties like gastroenterology, pain management, and oncology, creating sustained demand for precise, single-use injection needles that facilitate targeted therapeutic and diagnostic interventions within internal organs and cavities.
Other TrendsTechnological Innovation and Material Advancements
A key trend shaping the market is the continuous technological evolution of the needles themselves. Manufacturers are focusing on developing products with finer gauges, such as 23G, 24G, and 25G needles, to minimize patient trauma. Enhancements in flexibility and innovative tip designs are enabling more precise targeting and delivery of substances like drugs, sclerosing agents, or markers in delicate anatomical areas. This drive for innovation opens new application possibilities in fields like tumor ablation and advanced drug delivery systems.
Heightened Focus on Safety and Regulatory ComplianceThe critical trend of prioritizing patient safety remains a major driver. The disposable nature of these needles inherently reduces the risk of cross-contamination and hospital-acquired infections, aligning with stringent global healthcare hygiene standards. However, this focus on safety is coupled with the challenge of navigating complex and rigorous regulatory requirements for medical device approval. Manufacturers must invest significantly in quality control and clinical validation to meet these standards, which can be a barrier to entry but also serves to ensure high product reliability and market quality.
Regional Analysis: Disposable Endoscopic Injection Needle MarketEurope
Europe represents a significant and highly regulated market for disposable endoscopic injection needles, characterized by harmonized medical device regulations under the MDR. Countries like Germany, France, and the UK are major contributors, with a strong emphasis on minimally invasive surgical techniques. The region's well-established public and private healthcare systems facilitate broad access to advanced endoscopic procedures. Price sensitivity and robust procurement processes by hospital groups influence market dynamics, with a focus on cost-effectiveness alongside quality. Environmental concerns regarding single-use plastics are also beginning to shape product development and purchasing decisions, prompting manufacturers to consider sustainability in their offerings.
Asia-Pacific
The Asia-Pacific region is the fastest-growing market, fueled by increasing healthcare expenditure, rising prevalence of gastrointestinal diseases, and expanding medical tourism. Japan has a particularly advanced market with a high volume of endoscopic screening programs. China and India are experiencing rapid market expansion due to improving healthcare infrastructure and growing adoption of endoscopic techniques by a larger base of practitioners. The market is highly price-competitive, with local manufacturers playing an increasingly significant role. Variations in regulatory standards and reimbursement policies across different countries create a diverse and complex market landscape with substantial growth potential.
South America
The market in South America is emerging, with growth driven by gradual improvements in healthcare infrastructure and increasing awareness of advanced endoscopic procedures. Brazil is the largest market in the region, but economic volatility can impact the pace of adoption. Market penetration is often limited to major urban centers and private hospitals, with public healthcare systems facing budget constraints. The reliance on imported devices and currency fluctuations can affect pricing and availability. There is a growing focus on training healthcare professionals, which is expected to drive future demand for disposable endoscopic tools.
Middle East & Africa
This region shows nascent but promising growth, primarily concentrated in wealthy Gulf Cooperation Council (GCC) countries like Saudi Arabia and the UAE, which invest heavily in state-of-the-art medical facilities. These nations are hubs for medical tourism, driving demand for high-quality disposable devices. In other parts of the region, market development is slower, hindered by limited healthcare access and infrastructure challenges. The market is largely import-dependent, with distribution channels focused on key urban hospitals. Efforts to localize manufacturing and improve healthcare access are key factors that will influence future market dynamics.
This market research report offers a holistic overview of global and regional markets for the forecast period 20252032. It presents accurate and actionable insights based on a blend of primary and secondary research.
Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
Segmentation Analysis
By product type or category
By application or usage area
By end-user industry
By distribution channel (if applicable)
Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
Technology & Innovation
Emerging technologies and R&D trends
Automation, digitalization, sustainability initiatives
Impact of AI, IoT, or other disruptors (where applicable)
Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
Stakeholder Insights
This report is designed to support strategic decision-making for a wide range of stakeholders, including:
Pharmaceutical and biotech companies
Medical device and diagnostics manufacturers
Healthcare providers and hospital systems
Contract research and manufacturing organizations
Investors, consultants, and policy makers
-> Global Disposable Endoscopic Injection Needle market was valued at USD 1,649 million in 2024 and is projected to reach USD 2,870 million by 2032.
-> Key players include Olympus, Boston Scientific, Cook Medical, Steris, and Micro-tech, among others.
-> Key growth drivers include surge in minimally invasive procedures, technological advancements, and focus on patient safety.
-> North America is a dominant market, while Asia shows fastest growth potential.
-> Emerging trends include finer needle gauges, expanded applications in tumor ablation, and enhanced flexibility designs.
“The data provided by 24LifeScience was clear, well-organized, and useful for internal strategy planning. It helped us understand the competitive landscape more effectively.”
“We used one of their market overview reports for early-stage feasibility work. It gave us a helpful snapshot of current trends and key players in our therapeutic area.”
“I appreciated the team’s responsiveness and willingness to adjust the scope based on our feedback. The final report was aligned with our expectations and timelines.”
“Their custom report on clinical trial trends was a helpful reference as we explored new indications."
“As someone working on early product planning, I found their therapeutic area briefs quite useful. The information was presented in a way that made it easy to extract key takeaways.”
“We didn’t need anything overly complex—just solid, dependable data. 24LifeScience delivered exactly that, without unnecessary fluff.”
“Their reports gave us a good foundation to start our own market assessment. While we supplemented it with other data, this was a great starting point.”
“I’ve used a few of their reports for academic and grant writing purposes. They’re generally well-cited and reliable for understanding market scope.”
At 24LifeScience, we combine domain expertise with dependable research delivery. What truly differentiates us isn't just what we do — it's how we do it. Our clients trust us because we offer consistency, security, value, and most importantly, insight that drives action.
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
We uphold rigorous data validation processes to ensure every report is reliable, up-to-date, and based on credible sources.
24LifeScience powers research for top firms in 20+ nations.Chosen by leading life sciences companies worldwide.
We offer competitive pricing models that align with your project scope — no hidden charges, no lock-in. Tailored pricing for every scale and need.
8–10+ years of life sciences expertise turned into strategic insights.We don’t just summarize data we contextualize it.
Whether it's a ready-made report or a custom project, we deliver within the promised timeline With real-time updates